81 related articles for article (PubMed ID: 1323087)
1. An evaluation of human papillomavirus testing as part of referral to colposcopy clinics.
Cox JT; Schiffman MH; Winzelberg AJ; Patterson JM
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):389-95. PubMed ID: 1323087
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia.
Nuovo GJ; Blanco JS; Leipzig S; Smith D
Obstet Gynecol; 1990 Jun; 75(6):1006-11. PubMed ID: 2160630
[TBL] [Abstract][Full Text] [Related]
3. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
4. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
5. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
Layfield LJ; Qureshi MN
Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus in women. A three-year experience in a county hospital colposcopy clinic.
Cartwright PS; Dao AH; Reed GW
J Reprod Med; 1992 Feb; 37(2):167-9. PubMed ID: 1311381
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus screening for women with atypical Papanicolaou smears.
Borst M; Butterworth CE; Baker V; Kuykendall K; Gore H; Soong SJ; Hatch KD
J Reprod Med; 1991 Feb; 36(2):95-9. PubMed ID: 1849177
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
Fletcher AH; Wilkinson EJ; Knapik JA
J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
Cox JT; Lorincz AT; Schiffman MH; Sherman ME; Cullen A; Kurman RJ
Am J Obstet Gynecol; 1995 Mar; 172(3):946-54. PubMed ID: 7892889
[TBL] [Abstract][Full Text] [Related]
10. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population.
Zazove P; Reed BD; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT; Hruszczyk J
Arch Fam Med; 1993 Dec; 2(12):1250-8. PubMed ID: 8130906
[TBL] [Abstract][Full Text] [Related]
11. Detection of human papillomavirus DNA in patients referred to a family practice colposcopy clinic.
Holman JR
J Am Board Fam Pract; 1996; 9(3):162-6. PubMed ID: 8743228
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Papanicolaou smears. Comparison of cytology, colposcopy and cervical swab DNA hybridization.
Powell WS; McKenzie HJ
J Reprod Med; 1992 Jun; 37(6):525-8. PubMed ID: 1320120
[TBL] [Abstract][Full Text] [Related]
13. ViraPap: can it help to reduce the need for colposcopy?
Mareck DG; Woolard DG
Fam Pract Res J; 1991 Dec; 11(4):405-14. PubMed ID: 1662859
[TBL] [Abstract][Full Text] [Related]
14. Colposcopic survey of Papanicolaou test-negative cases with hyperkeratosis or parakeratosis.
Cecchini S; Iossa A; Ciatto S; Bonardi L; Confortini M; Cipparrone G
Obstet Gynecol; 1990 Nov; 76(5 Pt 1):857-9. PubMed ID: 2170888
[TBL] [Abstract][Full Text] [Related]
15. Detection of human papilloma virus in women referred for colposcopy. A comparison between different diagnostic methods.
Bodén E; Evander M; Wadell G; Bjersing L; von Schoultz B; Rylander E
Acta Obstet Gynecol Scand; 1990; 69(2):153-9. PubMed ID: 2166988
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing human papillomavirus of the female lower genital tract: failure of the Pap smear as a sole screening test.
Lonky NM; Mahoney A; Sauer MV
J Gynecol Surg; 1991; 7(3):183-9. PubMed ID: 10150073
[TBL] [Abstract][Full Text] [Related]
17. Comparison between colposcopic, cytologic, and histologic findings in women positive and negative for human papillomavirus DNA.
Moscicki AB; Broering J; Powell K; Klein J; Clayton L; Smith G; Boero S; Darragh TM; Brescia RJ; Palefsky J
J Adolesc Health; 1993 Mar; 14(2):74-9. PubMed ID: 8386548
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and cervical neoplasia: epidemiological considerations.
Grubb GS
Int J Epidemiol; 1986 Mar; 15(1):1-7. PubMed ID: 3007381
[TBL] [Abstract][Full Text] [Related]
19. HPV DNA and the risk of squamous intraepithelial lesions of the uterine cervix in young women.
Levine AJ; Harper J; Hilborne L; Rosenthal DL; Weismeier E; Haile RW
Am J Clin Pathol; 1993 Jul; 100(1):6-11. PubMed ID: 8394050
[TBL] [Abstract][Full Text] [Related]
20. Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.
Elfgren K; Rylander E; Rådberg T; Strander B; Strand A; Paajanen K; Sjöberg I; Ryd W; Silins I; Dillner J;
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):650-7. PubMed ID: 16150255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
